AlzeCure's NeuroRestore ACD856 to be presented at AD/PD 2025 - PharmaTimes Preclinical data highlights potential in treating Alzheimer's disease

#AlzeCure #AlzeCurePharmaAB #NeuroRestoreACD856 #Preclinicaldata #Alzheimersdisease #AD #ACD856 #biomarkers #diseasemodifyingpotential #NeuroRestorecompounds #NeuroRestoreplatform #Parkinsonsdisease #depression #Alzheimers #Parkinsons #NeurologicalDiseases
pharmatimes.com/news/alzecur...